Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
biote Corp.

biote Corp. (BTMD) Stock Overview

Explore biote Corp.’s financial performance, market position, analyst ratings, and future outlook.

BTMD●NASDAQ
HealthcareMedical - Care Facilities
$2.04
$0.20(8.93%)
U.S. Market opens in 10h 10m

biote Corp. (BTMD)

Meyka AI Score

Z

Key Financials

Market Cap90M
P/E Ratio4.24
EPS (TTM)$0.44
ROE-0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$1.38
3 Months$1.63
1 Year Target$0.33

BTMD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of biote Corp. (NASDAQ: BTMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, biote Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BTMD on the NASDAQ shows an RSI of 42.97, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.33 for the NASDAQ listing.

Key metrics behind biote Corp.'s NASDAQ-traded stock include a P/E ratio of 4.24 and a market capitalization of 90M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BTMD on the NASDAQ.

Price Performance (NASDAQ: BTMD)

1-Day Change
-8.93%
5-Day Change
-8.93%
1-Month Change
22.16%
3-Month Change
-8.11%
6-Month Change
-2.39%
Year-to-Date (YTD) Change
-21.54%
1-Year Change
-55.16%
3-Year Change
-70.09%
5-Year Change
-78.88%
All-Time (Max) Change
-79.70%

Contact Information

https://biote.com
844-604-1246
1875 West Walnut Hill Lane, Irving, TX, 75038

Company Facts

2,230 Employees
IPO DateApr 28, 2021
CountryUS
Actively Trading

Frequently Asked Questions